Tatva Chintan Pharma Chem Ltd. Investor Presentation

Tatva Chintan Pharma Chem Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter

Conference/Earnings Calls Alerts

Search Inside the pdf :

Tatva Chintan Pharma Chem Ltd.

05 May 2025

931.75

-2.22%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for the quarter and financial year ended 31 March 2025.

Tatva Chintan Pharma Chem Ltd.

28 Jan 2025

931.75

-2.22%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for the Quarter and Nine Months ended 31 December 2024.

Tatva Chintan Pharma Chem Ltd.

25 Oct 2024

931.75

-2.22%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for the Quarter and Half Year ended 30 September 2024.

Tatva Chintan Pharma Chem Ltd.

24 Jul 2024

931.75

-2.22%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for the quarter ended 30 June 2024.

Tatva Chintan Pharma Chem Ltd.

03 May 2024

931.75

-2.22%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for the quarter and financial year ended 31 March 2024.

Tatva Chintan Pharma Chem Ltd.

20 Jan 2024

931.75

-2.22%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for the Quarter and Nine Months Ended 31 December 2023.

Tatva Chintan Pharma Chem Ltd.

02 Nov 2023

931.75

-2.22%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for the Quarter and Half Year ended 30 September 2023.

Tatva Chintan Pharma Chem Ltd.

04 Aug 2023

931.75

-2.22%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation for the quarter ended 30 June 2023

Tatva Chintan Pharma Chem Ltd.

05 May 2023

931.75

-2.22%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed Investor Presentation for the quarter and financial year ended 31 March 2023. The above information shall be made available on the website of the Company at www.tatvachintan.com.

Tatva Chintan Pharma Chem Ltd.

24 Jan 2023

931.75

-2.22%

Investor Presentation

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed Investor Presentation for the quarter and nine months ended 31 December 2022. The above information shall be made available on the website of the Company at www.tatvachintan.com.